NCT05012202View on ClinicalTrials.gov

Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 10, 2022

Study Completion Date

December 10, 2022

Conditions

Blood Loss

Interventions

DEVICE

Hemi device

A sample of vaginal blood will be collected following delivery and analyzed by the device to provide a hematocrit level, which will be masked to the clinical team.

Trial Locations (1)

77555

UTMB, Galveston

All Listed Sponsors

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT05012202 - Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women | Biotech Hunter | Biotech Hunter